The diagnostic challenge of suspicious or positive malignant urine cytology findings when cystoscopy findings are normal: an outpatient blue-light flexible cystoscopy may solve the problem

References

• Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108.
   PubMed Web of Science ®Google Scholar
• Liedberg F, Hagberg O, Holmäng S, et al. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study. Scand J Urol. 2015;49(4):290–295.
   PubMed Web of Science ®Google Scholar
• Helenius M, Brekkan E, Dahlman P, et al. Bladder cancer detection in patients with gross hematuria: computed tomography urography with enhancement-triggered scan versus flexible cystoscopy. Scand J Urol. 2015;49(5):377–381.
   PubMed Web of Science ®Google Scholar
• Milicić V, Prvulović I, Panda N, et al. Diagnostic value of cytology of voided urine. Coll Antropol. 2014;38(2):617–620.
   PubMedGoogle Scholar
• Babjuk M, Burger M, Compérat E, et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update. Euro Urol. 2019;76(5):639–657.
   PubMed Web of Science ®Google Scholar
• Musser J, ÓShaughnessy M, Kim P, et al. Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer. J Urol. 2015;193(1):48–52.
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A. Bladder cancer: normal cystoscopy, malignant cytology in NMIBC: why biopsy? Nat Rev Urol. 2014;11(10):550–551.
   PubMed Web of Science ®Google Scholar
• Hara T, Takahashi M, Gondo T, et al. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases. Inter J Urol. 2009;16(3):293–298.
   PubMed Web of Science ®Google Scholar
• Sohn DW, Kim SW, Hong CG, et al. Risk factors of infectious complication after ureteroscopic procedures of the upper urinary tract. J Infect Chemother. 2013;19(6):1102–1108.
   PubMed Web of Science ®Google Scholar
• Marchioni M, Primiceri G, Cindolo L, et al. Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta‐analysis. BJU Int. 2017;120(3):313–319.
   PubMed Web of Science ®Google Scholar
• Erikson M, Petersen A, Andersen K, et al. Do repeated transurethral procedures under general anesthesia influence mortality in patients with non-invasive urothelial bladder cancer? A Danish national cohort study. Scand J Urol. 2020;54(4):281–289.
   PubMed Web of Science ®Google Scholar
• Dansk V, Malmström PU, Bläckberg M, et al. Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden. Future Oncol. 2016;12(8):1025–1038.
   PubMed Web of Science ®Google Scholar
• Burger M, Grossman HB, Droller M, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013;64(5):846–854.
   PubMed Web of Science ®Google Scholar
• Grossman HB, Gomella L, Fradet Y, et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol. 2007;178(1):62–67.
   PubMed Web of Science ®Google Scholar
• Schmidbauer J, Witjes F, Schmeller N, et al. M Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol. 2004;171(1):135–138.
   PubMed Web of Science ®Google Scholar
• Jocham D, Witjes F, Wagner S, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174(3):862–866.
   PubMed Web of Science ®Google Scholar
• Stenzl A, Burger M, Fradet Y, et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010;184(5):1907–1913.
   PubMed Web of Science ®Google Scholar
• Hermann GG, Mogensen K, Toft BG, et al. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies. Scand J Urol Nephrol. 2012;46(1):31–36.
   PubMed Web of Science ®Google Scholar
• Zare R, Grabe M, Hermann GG, et al. Can routine outpatient follow-up of patients with bladder cancer be improved? A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration. Res Rep Urol. 2018;10:151–157.
   PubMed Web of Science ®Google Scholar
• Daneshmand S, Patel S, Lotan Y, et al. Efficacy and safety of blue light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: a phase III, comparative multicenter study. J Urol. 2018;199(5):1158–1165.
   PubMed Web of Science ®Google Scholar
• Drejer D, Moltke AL, Nielsen AM, et al. DaBlaCa-11: photodynamic diagnosis in flexible cystoscopy-a randomized study with focus on recurrence. Urology. 2020;137:91–96.
   PubMed Web of Science ®Google Scholar
• Draga RO, Grimbergen MC, Kok ET, et al. Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guérin immunotherapy and mitomycin c intravesical therapy. Eur Urol. 2010;57(4):655–660.
   PubMed Web of Science ®Google Scholar
• McKenney J. Precursor lesions of the urinary bladder. Histopathology. 2019;74(1):68–76.
   PubMed Web of Science ®Google Scholar
• Kim L, Song JY, Choi SJ, et al. Cytologic features of prostatic adenocarcinoma in urine: comparison with urothelial carcinoma. Kor J Pathol. 2011;45:79–86.
   Google Scholar
• Tschirdewahn S, Harke NN, Hirner L, et al. Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy. World J Urol. 2020;38(6):1509–1515.
   PubMed Web of Science ®Google Scholar
• Zaak D, Ohlmann C, Stenzl A. [Current and established diagnostic modalities for bladder cancer]. Urologe A. 2018;57(6):657–664. German.
   PubMedGoogle Scholar
• Badalament RA, Hermansen DK, Kimmel M, et al. he sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer. 1987;60(7):1423–1427.
   PubMed Web of Science ®Google Scholar
• Nabi G, Greene D, O’Donnell MO, et al. Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up? J Clin Pathol. 2004;57(4):365–368.
   PubMed Web of Science ®Google Scholar
• Ströck V, Holmäng S. Is bladder tumour fulguration under local anaesthesia more painful than cystoscopy only? Scand J Urol. 2020;54(4):277–280.
   PubMed Web of Science ®Google Scholar